Capivasertib treatment associated with hypermetabolism of the spleen
Abstract Capivasertib has emerged as a promising treatment for advanced breast and prostate cancer. Here, we report two cases of metastatic breast cancer patients who developed splenic hypermetabolism on [18 F]-FDG PET/CT following treatment with capivasertib. To our knowledge, these are the first d...
Na minha lista:
| Principais autores: | , , |
|---|---|
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
Springer
2025-03-01
|
| Serier: | EJNMMI Reports |
| Fag: | |
| Online adgang: | https://doi.org/10.1186/s41824-024-00231-7 |
| Tags: |
Ingen Tags, Vær først til at tagge denne postø!
|